Insufficient scRNA-seq data for expression of GALP at single-cell level.
Insufficient scRNA-seq data for expression of GALP at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 85% | 7.56 | 193 / 226 | 20% | 0.48 | 80 / 406 |
brain | 48% | 2.31 | 1268 / 2642 | 1% | 0.02 | 5 / 705 |
ovary | 16% | 0.24 | 29 / 180 | 14% | 1.04 | 61 / 430 |
uterus | 15% | 0.32 | 25 / 170 | 3% | 0.13 | 14 / 459 |
stomach | 10% | 0.16 | 37 / 359 | 3% | 0.09 | 10 / 286 |
spleen | 14% | 0.30 | 33 / 241 | 0% | 0 | 0 / 0 |
thymus | 11% | 0.15 | 70 / 653 | 0% | 0 | 0 / 605 |
prostate | 10% | 0.17 | 25 / 245 | 0% | 0 | 0 / 502 |
adrenal gland | 9% | 0.15 | 24 / 258 | 0% | 0.01 | 1 / 230 |
lung | 7% | 0.12 | 43 / 578 | 2% | 0.09 | 20 / 1155 |
pancreas | 9% | 0.12 | 29 / 328 | 0% | 0 | 0 / 178 |
blood vessel | 8% | 0.12 | 111 / 1335 | 0% | 0 | 0 / 0 |
intestine | 7% | 0.10 | 66 / 966 | 1% | 0.09 | 5 / 527 |
peripheral blood | 8% | 0.12 | 71 / 929 | 0% | 0 | 0 / 0 |
breast | 7% | 0.13 | 34 / 459 | 0% | 0.00 | 2 / 1118 |
esophagus | 6% | 0.09 | 93 / 1445 | 1% | 0.05 | 2 / 183 |
adipose | 7% | 0.13 | 88 / 1204 | 0% | 0 | 0 / 0 |
heart | 6% | 0.08 | 49 / 861 | 0% | 0 | 0 / 0 |
skin | 5% | 0.07 | 90 / 1809 | 0% | 0 | 0 / 472 |
muscle | 5% | 0.07 | 39 / 803 | 0% | 0 | 0 / 0 |
bladder | 5% | 0.05 | 1 / 21 | 0% | 0 | 0 / 504 |
kidney | 3% | 0.07 | 3 / 89 | 1% | 0.04 | 8 / 901 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.02 | 1 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0050829 | Biological process | defense response to Gram-negative bacterium |
GO_0061844 | Biological process | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO_0032868 | Biological process | response to insulin |
GO_0007218 | Biological process | neuropeptide signaling pathway |
GO_0032098 | Biological process | regulation of appetite |
GO_0008150 | Biological process | biological_process |
GO_0042595 | Biological process | behavioral response to starvation |
GO_0005575 | Cellular component | cellular_component |
GO_0005576 | Cellular component | extracellular region |
GO_0005179 | Molecular function | hormone activity |
GO_0005515 | Molecular function | protein binding |
Gene name | GALP |
Protein name | Galanin-like peptide |
Synonyms | |
Description | FUNCTION: [Isoform 1]: Hypothalamic neuropeptide which binds to the G-protein-coupled galanin receptors (GALR1, GALR2 and GALR3). Involved in a large number of putative physiological functions in CNS homeostatic processes, including the regulation of gonadotropin-releasing hormone secretion.; FUNCTION: [Isoform 2]: Exhibits potent and dose-dependent vasoconstrictor and anti-edema activity in the cutaneous microvasculature, a physiologic effects which does not appear to be mediated via GALR1 or GALR2. Exhibits antimicrobial activity against Gram-negative bacterias, inducing bacterial membrane blebbing . . |
Accessions | Q9UBC7 ENST00000357330.7 [Q9UBC7-1] ENST00000590002.1 [Q9UBC7-2] ENST00000440823.1 [Q9UBC7-2] |